PD-1, the inhibitory receptor and marker of exhaustion on activated CD8+T cells, is commonly induced upon chronic infection and cancer leading to CD8+T cell dysfunction upon engagement by its ligand PD-L1 (CD274) (ref. 32). The gene discussed is CD274; the disease is cancer.